Could Anthropic's IPO Be Bigger Than SpaceX's?

Anthropic is reportedly considering a fall IPO at about a $2 trillion valuation, after its private valuation rose from $61.5 billion in early 2025 to $965 billion following a $65 billion May financing. The company said annualized revenue run rate increased from roughly $9 billion at the end of last year to $47 billion in May and $65 billion by July, driven by enterprise Claude products. The article cautions that investors should wait for the public S-1 and assess recurring revenue quality rather than chase a potentially hype-driven debut, particularly after SpaceX raised $86.2 billion at a roughly $2.1 trillion market capitalization.

Analysis

The key market mechanism is not whether Anthropic can achieve a headline valuation, but whether public investors will underwrite its implied forward revenue multiple before seeing gross margin, compute commitments, customer concentration, and cash-burn disclosures. At a ~$2T valuation, even a $65B annualized revenue figure implies roughly 31x sales before adjusting for revenue that may be usage-based, discounted through strategic partners, or offset by unusually high inference costs. The first public S-1 is therefore more likely to reprice the AI application layer than validate it: evidence of durable contribution margins would expand software/AI multiples, while weak margins would reinforce NVDA's position as the cleaner monetization vehicle.

AMZN has asymmetric strategic exposure: Anthropic's commercialization can drive incremental AWS consumption, but strong Claude adoption also increases AWS capex and power-network commitments before associated cloud revenue is fully realized. MU and SK Hynix benefit only if model deployment translates into sustained memory-content growth; an IPO valuation itself does not change HBM shipment volumes or pricing. The more immediate listed-market beneficiary is NDAQ, where large-float technology issuance, index inclusion and elevated turnover can lift transaction and data revenues, although this is modest relative to its existing earnings base.

The underappreciated risk is reflexivity in private AI marks. A weak aftermarket performance would not merely hurt a new listing; it could force valuation resets across late-stage AI portfolios and reduce strategic-investor appetite for subsidizing model providers. Conversely, disclosed multi-year enterprise commitments, net revenue retention above 130%, and declining inference cost per token would challenge the skepticism and could trigger another leg of capex expectations across NVDA, MU and hyperscalers over the following 6-18 months.

Key Decisions for Investors

• Do not initiate a directional position in the IPO before the public S-1; treat disclosure of gross margin, cash flow, committed compute obligations and top-customer concentration as gating data. A credible long setup requires recurring enterprise revenue and evidence that margins are expanding despite inference growth.
• Maintain NVDA as the preferred liquid AI exposure over a pre-IPO application-layer proxy for the next 1-3 months. The thesis fails if hyperscaler capex guidance weakens materially or disclosed Anthropic economics show that inference efficiency is reducing accelerator demand faster than workload growth.
• Consider a modest long NDAQ position into the expected filing/listing window, with a 3-6 month horizon, as an event-driven beneficiary of issuance, trading activity and index-related flows. Keep sizing small: risk/reward depends on actual float and market-volatility follow-through, not the issuer's headline valuation.
• Watch AMZN versus MU: favor AMZN only if AWS reports accelerating AI-related cloud revenue without a corresponding deterioration in segment operating margin; favor MU only after HBM contract pricing and bit-demand commentary confirm that AI deployment is converting to physical memory demand.
• If the IPO opens at an extreme premium and first-quarter public disclosures show slowing run-rate growth, rising sales concentration, or flat gross margin, evaluate a post-lockup short or put-spread rather than chasing the debut. The invalidation signal is sustained sequential revenue acceleration alongside clear operating-leverage evidence.